<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737005</url>
  </required_header>
  <id_info>
    <org_study_id>191020</org_study_id>
    <nct_id>NCT04737005</nct_id>
  </id_info>
  <brief_title>Evaluation of Marginal, Internal Adaptation and Clinical Performance of Endo-crowns Fabricated From Nano Hybrid and Lithium Di-silicate Ceramic Materials.</brief_title>
  <official_title>Evaluation of Marginal and Internal Adaptation and Clinical Performance of Endo-crowns Fabricated From Nano-ceramic Hybrid and Lithium Di-silicate Ceramic Materials (A Randomized Controlled Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the marginal and internal adaptation using silicon replica technique, which&#xD;
      will be measured by digital microscope and clinical Performance using modified USPHS scoring&#xD;
      system of Endo-crowns fabricated from Nano-ceramic Hybrid and Lithium di-silicate ceramic&#xD;
      materials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the marginal and internal adaptation using silicon replica technique, which&#xD;
      will be measured by digital microscope and clinical Performance using modified USPHS scoring&#xD;
      system of Endo-crowns fabricated from Nano-ceramic Hybrid and Lithium di-silicate ceramic&#xD;
      materials.&#xD;
&#xD;
      Primary outcome: Marginal gap of the two groups will be measured using Silicon replica&#xD;
      technique, Each replica will be sectioned bucco-lingually and mesio-distally into four&#xD;
      segments named (MB, DB, ML, DL) and each segment has five reference points assigned at&#xD;
      different positions, An overall of twenty reference points will be measured in each replica&#xD;
      sample using a digital microscope.&#xD;
&#xD;
      Secondary outcome:&#xD;
&#xD;
        -  Internal gap of the two groups will be measured using Silicon replica technique, which&#xD;
           will be measured by digital microscope.&#xD;
&#xD;
        -  Clinical Performance of the two groups will be evaluated using modified USPHS scoring&#xD;
           system. (Color match, Marginal discoloration, Surface texture and Gross fracture)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Marginal and internal gap evaluation</measure>
    <time_frame>1 year</time_frame>
    <description>marginal and internal gap will be evaluated by silicon replica technique, each replica will be sectioned into four segments named (MB, DB, ML, DL) and each segment had five reference points assigned at different positions, an overall of twenty reference points will be measured in each replica sample using a digital microscope. The measuring unit by microns</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical performance(Color match, Marginal discoloration, Surface texture and Gross fracture)</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical performance will be measured by modified USPHS criteria and the measuring unit by Alpha (A), Bravo (B) and Charlie (C)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Clinical Fit and Clinical Performance</condition>
  <arm_group>
    <arm_group_label>Nano-ceramic hybrid (Grandio Blocs) Endo-crown.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nano-ceramic hybrid ( intervention)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lithium di-silicate Ceramic (E.max CAD blocks) Endo-crown</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lithium di-silicate Ceramic ( Control)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nano-ceramic hybrid (Grandio Blocs) Endo-crown</intervention_name>
    <description>Nano-ceramic hybrid</description>
    <arm_group_label>Lithium di-silicate Ceramic (E.max CAD blocks) Endo-crown</arm_group_label>
    <arm_group_label>Nano-ceramic hybrid (Grandio Blocs) Endo-crown.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  From 18-50 years old, be able to read and sign the informed consent document.&#xD;
&#xD;
          -  Have no active periodontal or pulpal diseases, have teeth with good restorations.&#xD;
&#xD;
          -  Psychologically and physically able to withstand conventional dental procedures.&#xD;
&#xD;
          -  Patients planned for a single coverage restoration in the posterior area.&#xD;
&#xD;
          -  Able to return for follow-up examinations and evaluation.&#xD;
&#xD;
          -  Patients have root apex of molar without evident damage and no root fracture.&#xD;
&#xD;
          -  Good oral hygiene habits.&#xD;
&#xD;
          -  Have a complete root canal therapy molar necessitating an Endo-crown restoration.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient less than 18 or more than 50 years&#xD;
&#xD;
          -  Patients with severe clenching or bruxism.&#xD;
&#xD;
          -  Patient with active resistant periodontal diseases&#xD;
&#xD;
          -  Patients with poor oral hygiene and uncooperative patients&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Patients in the growth stage with partially erupted teeth&#xD;
&#xD;
          -  Psychiatric problems or unrealistic expectations&#xD;
&#xD;
          -  Patients with inadequate or low quality endodontic treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mai Salahel-din Abdel-azim</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

